更正：新型抗微管蛋白剂MPT0B169抑制非耐药和伊马替尼耐药的慢性髓性白血病细胞中的Bcr-Abl表达并诱导线粒体介导的凋亡。
Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
作者信息
Wong Shuit-Mun, Liu Fu-Hwa, Lee Yueh-Lun, Huang Huei-Mei
出版信息
PLoS One. 2017 Oct 11;12(10):e0186531. doi: 10.1371/journal.pone.0186531. eCollection 2017.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0148093.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0148093。]
相似文献
1
Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.更正：新型抗微管蛋白剂MPT0B169抑制非耐药和伊马替尼耐药的慢性髓性白血病细胞中的Bcr-Abl表达并诱导线粒体介导的凋亡。
PLoS One. 2017 Oct 11;12(10):e0186531. doi: 10.1371/journal.pone.0186531. eCollection 2017.
2
MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.新型微管蛋白抑制剂MPT0B169通过线粒体功能障碍和Mcl-1下调诱导耐紫杉醇急性髓系白血病细胞凋亡。
Tumour Biol. 2016 May;37(5):6065-72. doi: 10.1007/s13277-015-4380-4. Epub 2015 Nov 25.
3
Correction: MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.更正：微小RNA-1301介导的RanGAP1下调诱导BCR-ABL核内滞留以增强伊马替尼对慢性粒细胞白血病细胞的疗效。
PLoS One. 2017 Mar 7;12(3):e0173828. doi: 10.1371/journal.pone.0173828. eCollection 2017.
4
The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.多激酶抑制剂索拉非尼可诱导对甲磺酸伊马替尼高度耐药的bcr/abl+人白血病细胞凋亡，这与信号转导和转录激活因子5的抑制以及髓样细胞白血病-1的下调有关。
Mol Pharmacol. 2007 Sep;72(3):788-95. doi: 10.1124/mol.106.033308. Epub 2007 Jun 26.
5
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells.新型碘乙酰胺苯并呋喃衍生物 TR120 降低了 STAT5 的表达，并在伊马替尼敏感和伊马替尼耐药 BCR-ABL 表达的白血病细胞中诱导抗肿瘤作用。
Anticancer Drugs. 2013 Apr;24(4):384-93. doi: 10.1097/CAD.0b013e32835e64a0.
6
CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation.CD-200可诱导T315I突变的伊马替尼耐药慢性髓性白血病细胞凋亡并抑制Bcr-Abl信号传导。
Int J Oncol. 2015 Jul;47(1):253-61. doi: 10.3892/ijo.2015.2994. Epub 2015 May 11.
7
Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.吡啶硫酮镍通过Bcr/Abl依赖和Bcr/Abl非依赖机制诱导对伊马替尼耐药的慢性髓性白血病细胞凋亡。
J Hematol Oncol. 2016 Nov 25;9(1):129. doi: 10.1186/s13045-016-0359-x.
8
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation.HS-543可诱导具有T315I突变的伊马替尼耐药慢性髓性白血病细胞凋亡。
Oncotarget. 2015 Jan 30;6(3):1507-18. doi: 10.18632/oncotarget.2837.
9
Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines.BCR-ABL的过度产生会在甲磺酸伊马替尼耐药细胞系中诱导细胞凋亡。
Cancer. 2005 Jan 1;103(1):102-10. doi: 10.1002/cncr.20758.
10
Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway.通过 nutlin-3 协同激活线粒体凋亡途径增强表达 BCR/ABL 的细胞对伊马替尼诱导的凋亡。
Apoptosis. 2010 May;15(5):608-20. doi: 10.1007/s10495-010-0457-0.
本文引用的文献
1
MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.新型抗微管蛋白药物MPT0B169抑制非耐药和伊马替尼耐药的慢性髓性白血病细胞中的Bcr-Abl表达并诱导线粒体介导的凋亡。
PLoS One. 2016 Jan 27;11(1):e0148093. doi: 10.1371/journal.pone.0148093. eCollection 2016.
Zotero 插件